NCT06434480View on ClinicalTrials.gov

SBRT in HCC With Oligoprogression on Atezo-Bev

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2028

Conditions
HCC
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

"* For intrahepatic progression: 27.5-50Gy in 5 fractions over 2 weeks will be given.~* For extrahepatic progression: an aim to give ablative dose will be given."

Trial Locations (1)

Unknown

RECRUITING

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER